RESEARCHER PROFILE

Jae Cheol Lee

← Back to University of Ulsan

J

University of Ulsan

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentHER2/EGFR in Cancer ResearchLung Cancer Research StudiesCancer Genomics and Diagnostics

Jae Cheol Lee works in Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, HER2/EGFR in Cancer Research, Lung Cancer Research Studies, Cancer Genomics and Diagnostics. Recorded institutional associations include Asan Medical Center, University of Ulsan.

427Publications
9,276Citations
48H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

    2012 · 1,218 citations
  2. Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer

    2019 · 374 citations
  3. p-GaN Gate HEMTs With Tungsten Gate Metal for High Threshold Voltage and Low Gate Current

    2013 · 299 citations
  4. Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

    2008 · 220 citations
  5. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

    2012 · 201 citations
  6. Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs

    2010 · 186 citations
  7. Understanding the effects of chemical reactions at the cathode–electrolyte interface in sulfide based all-solid-state batteries

    2019 · 173 citations
  8. MET and AXL Inhibitor NPS-1034 Exerts Efficacy against Lung Cancer Cells Resistant to EGFR Kinase Inhibitors Because of MET or AXL Activation

    2013 · 143 citations
  9. Gastrointestinal metastasis of lung cancer with special emphasis on a long-term survivor after operation

    2008 · 123 citations
  10. Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance

    2016 · 121 citations
  11. p53 Enhances Gefitinib-Induced Growth Inhibition and Apoptosis by Regulation of Fas in Non–Small Cell Lung Cancer

    2007 · 118 citations
  12. Controlling work function of reduced graphite oxide with Au-ion concentration

    2009 · 116 citations
  13. Epithelial‐mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4‐ALK translocation

    2013 · 114 citations
  14. Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping

    2013 · 107 citations
  15. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4

    2020 · 103 citations
  16. Electronic and optical properties of Al2O3/SiO2 thin films grown on Si substrate

    2010 · 88 citations
  17. Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients

    2018 · 82 citations
  18. RNA sequencing identifies novel markers of non-small cell lung cancer

    2014 · 76 citations
  19. Enhanced Glycolysis Supports Cell Survival in EGFR-Mutant Lung Adenocarcinoma by Inhibiting Autophagy-Mediated EGFR Degradation

    2018 · 75 citations
  20. 18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis

    2009 · 73 citations
  21. Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer

    2013 · 73 citations
  22. Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer

    2016 · 67 citations
  23. Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer

    2023 · 67 citations
  24. Mobile Health Management Platform–Based Pulmonary Rehabilitation for Patients With Non–Small Cell Lung Cancer: Prospective Clinical Trial

    2019 · 64 citations
  25. Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors

    2009 · 63 citations

← Return to the university profile